BAK vs CC vs OLN Stock Comparison

Braskem, Chemours and Olin Prices as of Nov 13, 2026 Peers: Industry group
BAK Braskem Sa
$1.14 -38.0% 1M -58.8% 1Y
Market cap
$754.88M
P/E
–
Revenue (TTM)
—
Div. yield
–
Commodity Chemicals Basic Materials
1 win
CC Chemours Co
$13.28 +3.3% 1M +8.2% 1Y
Market cap
$1.89B
P/E
–
Revenue (TTM)
$5.84B
Div. yield
0.03%
Commodity Chemicals Basic Materials
6 wins
OLN OLIN Corp
$17.46 +16.2% 1M -15.9% 1Y
Market cap
$1.94B
P/E
–
Revenue (TTM)
$6.74B
Div. yield
–
Commodity Chemicals Basic Materials
3 wins

Head to Head

10 decided of 12

Chemours leads on 6 of the 12 questions below (Chemours 6, Olin 3, Braskem 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBAKCCOLNLeader
Larger companyMarket capitalisation $754.88M $1.89B $1.94B OLN
Cheaper on earningsLower P/E, profitable companies only -0.5x -12.3x -8.6x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 2.1x 15.1x — BAK
Faster revenue growthRevenue growth, trailing twelve months — +0.1% -0.7% CC
More profitableNet margin, trailing twelve months — -2.6% -3.3% CC
Better return on capitalReturn on invested capital — 0.0% -2.1% CC
Less leveragedLower net debt / EBITDA — 8.6x 8.0x OLN
Higher dividend yieldTrailing dividend yield 0.00% 0.03% 0.00% –
Better 1-year returnPrice return, last 12 months -58.8% +8.2% -15.9% CC
Better 5-year returnAnnualised price return, 5 years -42.3%/yr -16.7%/yr -23.0%/yr CC
Less volatileAnnualised volatility, 1 year 94.6% 61.9% 52.7% OLN
Higher overall scoreMean of the five percentile scores vs peers — 49/100 44/100 CC

Percentile Scorecard

BAKCCOLN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBAKCCOLN
Valuation 26 #71 of 96 57 #42 of 96 78 #22 of 96
Growth – 88 #12 of 92 4 #88 of 92
Profitability – 41 #53 of 89 34 #59 of 89
Financial Health 6 #90 of 96 18 #79 of 96 17 #80 of 96
Shareholder Returns – 40 #48 of 79 87 #11 of 79
Overall – 49 44
  • BAK ranked among 99 companies in Chemicals
  • CC ranked among 99 companies in Chemicals
  • OLN ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBAKCCOLNSPY
1 month -38.0%+3.3%+16.2% -2.0%
3 months -41.5%-16.2%-8.6% -2.8%
6 months -76.7%-42.6%-34.8% +2.0%
Year to date -61.4%+12.6%-16.2% +10.6%
1 year -58.8%+8.2%-15.9% +12.2%
3 years -86.1%-50.5%-62.8% +68.1%
3 years, per year -48.2%-20.9%-28.1% +18.9%
5 years -93.6%-60.0%-72.9% +61.4%
5 years, per year -42.3%-16.7%-23.0% +10.1%
10 years -93.2%-35.9%-28.4% +248.5%
10 years, per year -23.5%-4.3%-3.3% +13.3%

Risk

MeasureBAKCCOLNSPY
Volatility, 1Y 94.6%61.9%52.7% 13.6%
Downside volatility, 1Y 102.7%68.2%54.3% 13.9%
Beta vs S&P 500, 1Y 1.291.450.35 1.00
Return / volatility, 1Y -0.620.13-0.30 0.90
Max drawdown, 5Y -95.5%-79.0%-78.0% -25.4%
From 52-week high -77.3%-52.5%-42.1% -3.2%
52-week high $5.02$27.94$30.14 $779.14
52-week low $1.06$10.48$14.72 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBAKCCOLN
P/E now vs peer median -0.5xmedian 23.4x -13.0xmedian 23.4x -8.8xmedian 23.4x
P/S now vs peer median 0.1xmedian 1.3x 0.3xmedian 1.3x 0.3xmedian 1.3x
EV/EBITDA now vs peer median —median 12.7x 14.0xmedian 12.7x 13.7xmedian 12.7x
P/FCF now vs peer median -0.7xmedian 17.0x 9.5xmedian 17.0x 9.0xmedian 17.0x
P/B now vs peer median -0.3xmedian 1.5x 12.8xmedian 1.5x 1.2xmedian 1.5x
PEG now vs peer median —median 1.72 -0.60median 1.72 0.26median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBAKCCOLN
Revenue – $5.84B $6.74B
Gross profit – $885.00M $450.00M
Operating income – $37.00M -$129.10M
Net income – -$154.00M -$225.10M
Free cash flow – $211.00M $221.50M
R&D – $104.00M –
EPS (diluted) – $-1.01 $-1.96
Cash & equivalents $1.92B $698.00M $214.80M
Total debt $9.79B $3.83B $3.01B
Shares (diluted) 797.21M 151.91M 115.00M
Enterprise value -$9.55B -$711.88M $1.19B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBAKCCOLN
P/E -0.5x -13.0x -8.8x
P/FCF -0.7x 9.5x 9.0x
P/Operating cash flow – 5.0x 5.1x
P/S 0.1x 0.3x 0.3x
P/B -0.3x 12.8x 1.2x
P/Tangible book -0.3x 13.0x 1.3x
EV/EBITDA – 14.0x 13.7x
EV/EBIT – 138.8x -37.1x
EV/Revenue – 0.9x 0.7x
EV/FCF – 24.3x 21.6x
EV/Operating cash flow – 12.8x 12.3x
PEG (3Y EPS CAGR) – -0.60 0.26

Growth

14 metrics
MetricBAKCCOLN
Revenue growth (1Y) – 0.1% -0.7%
Revenue CAGR (3Y) – -1.2% -2.2%
Gross profit growth (1Y) – -12.5% -28.4%
Gross profit CAGR (3Y) – -10.9% -30.9%
Operating income growth (1Y) – 1,133% -161.7%
Operating income CAGR (3Y) – 29.0% -29.0%
Net income growth (1Y) – 55.9% -531.2%
Net income CAGR (3Y) – 21.3% -33.4%
EPS growth (1Y) – 56.3% -520.7%
EPS CAGR (3Y) – 21.6% -34.1%
Operating cash flow growth (1Y) – 50.9% 32.6%
Operating cash flow CAGR (3Y) – 19.4% -26.1%
Free cash flow growth (1Y) – 1,858% 176.2%
Free cash flow CAGR (3Y) – 72.7% -32.8%

Profitability

14 metrics
MetricBAKCCOLN
Gross margin – 15.2% 6.7%
EBITDA margin – 6.3% 5.2%
Operating margin – 0.6% -1.9%
Pretax margin – 2.3% -4.4%
Net margin – -2.6% -3.3%
FCF margin – 3.6% 3.3%
Operating cash flow margin – 6.8% 5.8%
Return on equity – -285.2% -13.1%
Return on assets – -2.1% -3.0%
Return on invested capital – 0.0% -2.1%
Return on capital employed – 0.7% -2.2%
Asset turnover – 0.8x 0.9x
Cash conversion (OCF / net income) – -2.6x -1.7x
Stock comp / revenue – 0.4% 0.3%

Financial Health

11 metrics
MetricBAKCCOLN
Debt / assets 65.5% 52.6% 40.7%
Debt / equity -3.2x 24.6x 1.8x
Net debt / EBITDA – 8.6x 8.0x
Debt / FCF – 18.2x 13.6x
Liabilities / assets 120.2% 97.9% 76.8%
Equity / assets -20.2% 2.1% 23.2%
Interest coverage – 0.1x -0.7x
Current ratio 0.8x 1.8x 1.5x
Quick ratio 0.5x 0.9x 0.9x
Cash ratio 0.3x 0.4x 0.1x
Altman Z-score – 1.43 1.55

Shareholder Returns

7 metrics
MetricBAKCCOLN
Dividend yield – 2.7% 4.6%
Net buyback yield – -0.2% 0.3%
Shareholder yield 0.0% 2.5% 4.9%
Payout ratio (earnings) – -35.1% –
Payout ratio (FCF) – 25.6% –
Dividend growth (1Y) – -45.5% –
Dividend CAGR (3Y) – -28.7% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBAKCCOLN
Forward P/E 2.1xFY2026 15.1xFY2026 –
EPS, next fiscal year $0.54FY2026 $0.88FY2026 $-0.59FY2026
EPS growth, next FY – -7.4%FY2026 –
EPS growth, the year after -313.0% +109.1% –
Revenue, next fiscal year $14.98BFY2026 $5.76BFY2026 $6.35BFY2026
Revenue growth, next FY +7.3%FY2026 -0.9%FY2026 -6.4%FY2026
Revenue growth, the year after -1.1% +2.7% +15.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBAKCCOLN
Held by institutions 2.3% 89.4% 99.7%
Institutions holding 63 472 413
Change in shares held, QoQ +157.7% +2.8% +1.4%
Institutions buying 32 213 215
Institutions selling 16 127 121
Buyers to sellers 2.00 1.68 1.78

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BAKCCOLN
BAK 1.00 0.19 0.25
CC 0.19 1.00 0.47
OLN 0.25 0.47 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BAK, CC and OLN?

Olin (OLN) is the largest by market capitalisation: Braskem (BAK) $754.88M, Chemours (CC) $1.89B, Olin (OLN) $1.94B.

Which company is growing faster?

Chemours (CC) grew revenue fastest over the trailing twelve months: Chemours (CC) +0.1%, Olin (OLN) -0.7%.

Which company is more profitable?

Chemours (CC) has the highest net margin (Chemours (CC) -2.6%, Olin (OLN) -3.3%). On return on invested capital, Chemours (CC) leads (Chemours (CC) 0.0%, Olin (OLN) -2.1%).

Which stock has performed better?

Over the past year Chemours (CC) returned the most: Braskem (BAK) -58.8%, Chemours (CC) +8.2%, Olin (OLN) -15.9%. Over five years, Chemours (CC) compounded fastest (Braskem (BAK) -42.3%/yr, Chemours (CC) -16.7%/yr, Olin (OLN) -23.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Braskem (BAK) 0.00%, Chemours (CC) 0.03%, Olin (OLN) 0.00%. Braskem (BAK) and Olin (OLN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Olin (OLN) has been the steadiest (Braskem (BAK) 94.6%, Chemours (CC) 61.9%, Olin (OLN) 52.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BAK, CC and OLN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Chemours (CC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.